BCOR and sarcoma: To enable better characterization of these rare aggressive sarcomas, we suggest reporting them separately as “ZC3H7A/B::BCOR fusion fibromyxoid sarcoma of soft tissue,” until further data and dee functional and epigenetic analyses establish or rule out their presumed relationship to malignant OFMT and other BCOR-rearranged sarcomas.